Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Change in Cash (2016 - 2025)

Historic Change in Cash for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to -$890536.0.

  • Cumberland Pharmaceuticals' Change in Cash fell 79406.12% to -$890536.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.3 million, marking a year-over-year decrease of 11740.65%. This contributed to the annual value of -$357440.0 for FY2024, which is 7511.46% up from last year.
  • Per Cumberland Pharmaceuticals' latest filing, its Change in Cash stood at -$890536.0 for Q3 2025, which was down 79406.12% from $978868.0 recorded in Q2 2025.
  • In the past 5 years, Cumberland Pharmaceuticals' Change in Cash registered a high of $1.9 million during Q2 2023, and its lowest value of -$9.8 million during Q1 2022.
  • Its 5-year average for Change in Cash is -$503002.7, with a median of $216432.0 in 2022.
  • Within the past 5 years, the most significant YoY rise in Cumberland Pharmaceuticals' Change in Cash was 66690.44% (2022), while the steepest drop was 587903.91% (2022).
  • Cumberland Pharmaceuticals' Change in Cash (Quarter) stood at $1.2 million in 2021, then plummeted by 81.93% to $216432.0 in 2022, then plummeted by 186.1% to -$186341.0 in 2023, then surged by 368.02% to $499430.0 in 2024, then plummeted by 278.31% to -$890536.0 in 2025.
  • Its Change in Cash stands at -$890536.0 for Q3 2025, versus $978868.0 for Q2 2025 and -$2.9 million for Q1 2025.